Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/12/2014 12/15/2014 12/16/2014 12/17/2014 12/18/2014 Date
33.11(c) 32.755(c) 32.75(c) 33.47(c) 33.81 Last
1 600 570 2 324 643 1 237 242 1 545 540 1 181 677 Volume
-2.14% -1.07% -0.02% +2.20% +1.02% Change
More quotes
Company
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company.It focuses on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic... 
Sector
Pharmaceuticals
Calendar
01/27 | 08:30amShareholder meeting
More about the company
Surperformance© ratings of Auxilium Pharmaceuticals,
Trading Rating : - Investor Rating :
More Ratings
Chart AUXILIUM PHARMACEUTICALS,
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 399 M
EBIT 2014 16,6 M
Net income 2014 -
Debt 2014 479 M
Yield 2014 -
Sales 2015 484 M
EBIT 2015 105 M
Net income 2015 -
Debt 2015 364 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 5,47x
EV / Sales 2015 4,28x
Capitalization 1 708 M
More Financials
Latest news on AUXILIUM PHARMACEUTICALS,
1d ago AUXILIUM PHARMACEUTICALS : Announces Date for Special Meeting of Stockholders
2d ago AUXILIUM PHARMACEUTICALS : Other Events (form 8-K)
2d ago AUXILIUM PHARMACEUTICALS : Reports Stockholders Special Meeting
6d ago AUXILIUM PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form..
7d ago AUXILIUM PHARMACEUTICALS : Announces Date for Special Meeting of Stockholders
12/04 AUXILIUM PHARMACEUTICALS : Presents STENDRA Data At SMSNA Scientific Meeting
12/03 AUXILIUM PHARMACEUTICALS : Presents XIAFLEX For Peyronie's Disease Data At SMSNA..
11/26 AUXILIUM PHARMACEUTICALS : Endo Announces Early Termination of HSR Act Waiting P..
More news
Sector news
1h ago Roche to pay up to $489 million for next-generation antibody developer
2h ago MERCK : buys Swiss biotech with promising cancer drug
3h ago France fines household product firms 951 million euros for price fixing
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF